Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Decreased skin microcirculation correlates with serum albumin and relates to later development of skin defects, cardiovascular events and occurrence of death in hemodialyzed patients2009 | First Faculty of Medicine
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Hypolipidemic drugs and diabetes mellitus2009 | First Faculty of Medicine
- Combined hypolipidemic treatment in jpatients with high cardiovascular (CV) risk2008 | First Faculty of Medicine
- MIAC syndrome (malnutrition, inflammation, atherosclerosis, calcification)2007 | First Faculty of Medicine
- Fibrates in treatment of dyslipoproteinemia2006 | First Faculty of Medicine
- Statins in the treatment of dyslipidemia2005 | First Faculty of Medicine
- The impact of abnormalities of fatty acid metabolism in nonagenarians on dementia2004 | First Faculty of Medicine
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Loading network view...